Skip to main content
Top
Published in: Supportive Care in Cancer 6/2013

01-06-2013 | Original Article

International palliative care experts’ view on phenomena indicating the last hours and days of life

Authors: Franzisca Domeisen Benedetti, Christoph Ostgathe, Jean Clark, Massimo Costantini, Maria Laura Daud, Barbara Grossenbacher-Gschwend, Richard Latten, Olav Lindqvist, Andreja Peternelj, Stefanie Schuler, Kali Tal, Agnes van der Heide, Steffen Eychmüller, on behalf of OPCARE9

Published in: Supportive Care in Cancer | Issue 6/2013

Login to get access

Abstract

Background

Providing the highest quality care for dying patients should be a core clinical proficiency and an integral part of comprehensive management, as fundamental as diagnosis and treatment. The aim of this study was to provide expert consensus on phenomena for identification and prediction of the last hours or days of a patient’s life. This study is part of the OPCARE9 project, funded by the European Commission’s Seventh Framework Programme.

Method

The phenomena associated with approaching death were generated using Delphi technique. The Delphi process was set up in three cycles to collate a set of useful and relevant phenomena that identify and predict the last hours and days of life. Each cycle included: (1) development of the questionnaire, (2) distribution of the Delphi questionnaire and (3) review and synthesis of findings.

Results

The first Delphi cycle of 252 participants (health care professionals, volunteers, public) generated 194 different phenomena, perceptions and observations. In the second cycle, these phenomena were checked for their specific ability to diagnose the last hours/days of life. Fifty-eight phenomena achieved more than 80 % expert consensus and were grouped into nine categories. In the third cycle, these 58 phenomena were ranked by a group of palliative care experts (78 professionals, including physicians, nurses, psycho–social–spiritual support; response rate 72 %, see Table 1) in terms of clinical relevance to the prediction that a person will die within the next few hours/days. Twenty-one phenomena were determined to have “high relevance” by more than 50 % of the experts. Based on these findings, the changes in the following categories (each consisting of up to three phenomena) were considered highly relevant to clinicians in identifying and predicting a patient’s last hours/days of life: “breathing”, “general deterioration”, “consciousness/cognition”, “skin”, “intake of fluid, food, others”, “emotional state” and “non-observations/expressed opinions/other”.

Conclusion

Experts from different professional backgrounds identified a set of categories describing a structure within which clinical phenomena can be clinically assessed, in order to more accurately predict whether someone will die within the next days or hours. However, these phenomena need further specification for clinical use.
Footnotes
1
Five core themes, pertinent to the care of cancer patients in the last days of life, were structured as primary work packages.
 
2
Country representatives provided easy access to health care professionals and volunteers in the field of palliative care in each OPCARE9 country.
 
3
Consists in a selection of qualitative techniques for systematic text analysis
 
Literature
1.
go back to reference Scott K (2010) Incidence of sudden, unexpected death in a specialist palliative care inpatient setting. Palliat Med 24(4):449–450PubMedCrossRef Scott K (2010) Incidence of sudden, unexpected death in a specialist palliative care inpatient setting. Palliat Med 24(4):449–450PubMedCrossRef
2.
go back to reference Behl D, Jatoi A (2010) What do oncologists say about chemotherapy at the very end of life? Results from a semiqualitative survey. J Palliat Med 13(7):831–835PubMedCrossRef Behl D, Jatoi A (2010) What do oncologists say about chemotherapy at the very end of life? Results from a semiqualitative survey. J Palliat Med 13(7):831–835PubMedCrossRef
3.
go back to reference Lau F, Cloutier-Fisher D, Kuziemsky C, Black F, Downing M, Borycki E et al (2007) A systematic review of prognostic tools for estimating survival time in palliative care. J Palliat Care 23(2):93–112PubMed Lau F, Cloutier-Fisher D, Kuziemsky C, Black F, Downing M, Borycki E et al (2007) A systematic review of prognostic tools for estimating survival time in palliative care. J Palliat Care 23(2):93–112PubMed
4.
go back to reference Chiang JK, Cheng YH, Koo M, Kao YH, Chen CY (2010) A computer-assisted model for predicting probability of dying within 7 days of hospice admission in patients with terminal cancer. Jpn J Clin Oncol 40(5):449–455PubMedCrossRef Chiang JK, Cheng YH, Koo M, Kao YH, Chen CY (2010) A computer-assisted model for predicting probability of dying within 7 days of hospice admission in patients with terminal cancer. Jpn J Clin Oncol 40(5):449–455PubMedCrossRef
5.
go back to reference Toscani P, Brunelli C, Miccinesi G, Costantini M, Gallucci M, Tamburini M et al (2005) Predicting survival in terminal cancer patients: clinical observation or quality-of-life evaluation? Palliat Med 19(3):220–227PubMedCrossRef Toscani P, Brunelli C, Miccinesi G, Costantini M, Gallucci M, Tamburini M et al (2005) Predicting survival in terminal cancer patients: clinical observation or quality-of-life evaluation? Palliat Med 19(3):220–227PubMedCrossRef
6.
go back to reference Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmüller S et al (2005) Prognostic factors in advanced cancer patients: evidence-based clinical recommendations—a study by steering committee of the European Association for Palliative Care. J Oncol 23(25):6240–6248CrossRef Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmüller S et al (2005) Prognostic factors in advanced cancer patients: evidence-based clinical recommendations—a study by steering committee of the European Association for Palliative Care. J Oncol 23(25):6240–6248CrossRef
7.
go back to reference Morita T, Tsunoda J, Inoue S, Chihara S (1999) The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer 7(3):128–133PubMedCrossRef Morita T, Tsunoda J, Inoue S, Chihara S (1999) The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer 7(3):128–133PubMedCrossRef
8.
go back to reference Ellershaw JE, Wilkinson S (2010) Care of the dying: a pathway to excellence, 2nd edn. Oxford University Press, OxfordCrossRef Ellershaw JE, Wilkinson S (2010) Care of the dying: a pathway to excellence, 2nd edn. Oxford University Press, OxfordCrossRef
9.
go back to reference Higginson Irene J, Addington-Hall Julia M (2005) The epidemiology of death and symptoms. In: Doyle D, Hanks G, Cherny N, Calman K (eds) Oxford textbook of palliative medicine, 3rd edn. Oxford University Press, Oxford, pp 14–24 Higginson Irene J, Addington-Hall Julia M (2005) The epidemiology of death and symptoms. In: Doyle D, Hanks G, Cherny N, Calman K (eds) Oxford textbook of palliative medicine, 3rd edn. Oxford University Press, Oxford, pp 14–24
10.
go back to reference King LS (1984) Medical thinking: a historical preface. Princeton University Press, Princeton King LS (1984) Medical thinking: a historical preface. Princeton University Press, Princeton
11.
go back to reference Biondi Patricia D, Nekolaichuk CL, Stiles C, Fainsinger R, Hagen NA (2008) Applying the Delphi process to palliative care tool development: lessons learned. Support Care Cancer 16:935–942CrossRef Biondi Patricia D, Nekolaichuk CL, Stiles C, Fainsinger R, Hagen NA (2008) Applying the Delphi process to palliative care tool development: lessons learned. Support Care Cancer 16:935–942CrossRef
12.
go back to reference Franks PJ, Salisbury C, Bosanquet N, Wilkinson EK, Kite S, Naysmith A et al (2000) The level of need for palliative care: a systematic review of literature. Palliative Med 14(2):93–104CrossRef Franks PJ, Salisbury C, Bosanquet N, Wilkinson EK, Kite S, Naysmith A et al (2000) The level of need for palliative care: a systematic review of literature. Palliative Med 14(2):93–104CrossRef
13.
go back to reference Mayring P (2000) Qualitative content analysis. Qual Soc Res 1(2) Mayring P (2000) Qualitative content analysis. Qual Soc Res 1(2)
14.
go back to reference Treibel A (2000) Einführung in soziologische Theorien der Gegenwart, 5th edn. Leske + Budrich, OpladenCrossRef Treibel A (2000) Einführung in soziologische Theorien der Gegenwart, 5th edn. Leske + Budrich, OpladenCrossRef
15.
16.
go back to reference Yun AJ (2008) The hegemony of empiricism: the opportunity for theoretical science in medicine. Med Hypotheses 70(3):478–481PubMedCrossRef Yun AJ (2008) The hegemony of empiricism: the opportunity for theoretical science in medicine. Med Hypotheses 70(3):478–481PubMedCrossRef
17.
go back to reference Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, McIntyre L, Tulsky JA (2000) Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA 284(19):2476–2482PubMedCrossRef Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, McIntyre L, Tulsky JA (2000) Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA 284(19):2476–2482PubMedCrossRef
18.
Metadata
Title
International palliative care experts’ view on phenomena indicating the last hours and days of life
Authors
Franzisca Domeisen Benedetti
Christoph Ostgathe
Jean Clark
Massimo Costantini
Maria Laura Daud
Barbara Grossenbacher-Gschwend
Richard Latten
Olav Lindqvist
Andreja Peternelj
Stefanie Schuler
Kali Tal
Agnes van der Heide
Steffen Eychmüller
on behalf of OPCARE9
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 6/2013
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1677-3

Other articles of this Issue 6/2013

Supportive Care in Cancer 6/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine